KOD
Kodiak Sciences Inc

3,597
Loading...
Loading...
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
109

Frequently Asked Questions

What is Market Cap of Kodiak Sciences Inc?
What is the 52-week high for Kodiak Sciences Inc?
What is the 52-week low for Kodiak Sciences Inc?
What is Kodiak Sciences Inc stock price today?
What was Kodiak Sciences Inc stock price yesterday?
What is the PE ratio of Kodiak Sciences Inc?
What is the Price-to-Book ratio of Kodiak Sciences Inc?
What is the 50-day moving average of Kodiak Sciences Inc?
How many employess does Kodiak Sciences Inc has?

Latest KOD News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.